Sat, Jul 12, 2014, 7:26 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

fghton 8 posts  |  Last Activity: Jun 20, 2014 10:25 AM Member since: Jun 18, 2002
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    why is this up 43% in one month??

    by richard8547 Jun 16, 2014 4:22 PM
    fghton fghton Jun 20, 2014 10:25 AM Flag

    Cause golong said it would be almost a month ago!

  • NPSP....wow.... I bought small hoping to add....Bad guess huh? Great job!!! Congrats!

  • Reply to

    TSRX to DRTX. Now on to TTPH or CEMP?

    by titleist3iron78 May 29, 2014 8:42 AM
    fghton fghton May 29, 2014 9:57 AM Flag

    Both are good picks.... TTPH is in gram negative bacteria and CEMP gram positive. If I were you I'd buy both.
    But don't wait for the small "maybe" payment on the TSRX buyout deal...I'd buy both now while the price is right. Next year they could both be up by 50% or more...

  • Not sure why everyone is bantering stuff back and forth about posters trying to manipulate the price of the stock, etc. Could be happening....might not be..and better yet, who cares at this juncture. All long time longs nerves are kinda frayed at this juncture having watched the stock go down from $6.69 to $2.84 in less than five months . Mine included by the way from a large position bought in the mid $4's....lol....

    But isn't the bottom line coming pretty darn soon? The platform either works for surgical scarring, or it doesn't.
    If it's a flop the stock goes down to $1 give or take .50... If it works well it goes to $5-$6. If it works great...$8-$10. What else is there to talk about right now?

  • fghton fghton May 27, 2014 11:50 PM Flag

    The stock went down on the FDA news after a run up in anticipation of it. Catalysts going forward are what?

    A buyout? Perhaps, but that's still just speculation. Trial results for the one dosage regime?....A year away perhaps from results. Launch of the product? Nervous time for the company and shareholders. Going it alone is not easy gang, and is definitely expensive to do starting up. To fund it...A secondary? You betcha. Count on it within the next 30 days or so IMHO. Dilution? That is what the market is concerned about right now IMHO. An established large marketing partner if they go it alone? Would be nice.

    Where does the price trade from in the weeks ahead... $12.50-$16.... $12.50 if a secondary. That's when I go back into the stock, and large too! IMHO! GLTALs

  • fghton fghton Apr 15, 2014 6:55 PM Flag

    Why would this stock bounce at all except perhaps by .20? What news could they release to move it up? If anything more dilution coming. BB's and others still are up 5x's their investment. Psoriasis trials will not have new results for many months to come. Do you think the new trials will show any major difference than what has already been reported? Not an issue of dosage really. It just didn't work. Definition of insanity..."Doing the same thing over and over again, but expecting a different result."

  • Reply to

    JMP ALNY Price Target....$110!!?

    by golongin2008 Apr 14, 2014 10:07 PM
    fghton fghton Apr 15, 2014 9:45 AM Flag

    rmsacc.... Dead on. RNAi and big pharma are having troubles because they don't have the holy grail to deliver it systemically. We darn will might. If the anti scarring delivery works a whole new ballgame in
    RNAi evolves from it. PB will rush to get involved with RXII. If it doesn't work...Well then we'll be another IDRA huh? GLYAL's!

  • Already broken what support PCTC had at $90 it had so next stop is $80. Yes....great potential in this company but at 6.6 billion certainly not cheap especially since JNJ owns 50% to the rights for the drug (I believe in the US?). Book of $8.46. Scripts looking like around 200-250 million in 2014. Tough to support a 6.6 billion dollar company on that. Lots of trials on-going means lots of expenses before you hit pay dirt.

    No doubt an exciting potential game changer company but man... 6.6 billion for 250 million in sales?
    Heck double or even triple that for 2015 and still very expensive given JNJs interest.

AMRN
1.59-0.02(-1.24%)Jul 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Potbelly Corporation
NasdaqGSFri, Jul 11, 2014 4:00 PM EDT
Immersion Corporation
NasdaqGSFri, Jul 11, 2014 4:00 PM EDT